Literature DB >> 11485172

Enhancement of ibuprofen dissolution via wet granulation with beta-cyclodextrin.

M K Ghorab1, M C Adeyeye.   

Abstract

The purpose was to investigate the effect of wet granulation with beta-cyclodextrin (betaCD) on the enhancement of ibuprofen (IBU) dissolution. The effect of the granulation variables on the physical properties as well as the dissolution of tablets prepared from these granules was also examined. Granulation was performed using three granulating solvents: water, ethanol (95 vol%), and isopropanol. Granules were either oven-dried for 2 h or air-dried for 3 days. The granules or respective physical mixtures were compressed into tablets. Powder X-ray diffraction showed that oven-dried granulation resulted in less amorphous entities thatfacilitated IBU-betaCD complexation in solution and enhanced the dissolution of the corresponding tablets compared to the physical mixture with or without oven drying. In contrast, air-dried granulation did not cause any differences in the X-ray diffraction pattern (crystallinity) or the dissolution compared to the physical mixture without drying. Isopropanol and water, as granulating solvents, enhanced the dissolution of the oven-dried batches more than ethanol. The Differential scanning calorimetry (DSC) and Thermogravimetric analysis (TGA) data showed that tablets prepared from oven-dried granules, but not air-dried granules, had lower AH values and percent loss in weight, respectively, than those prepared from the physical mixture as a result of the expulsion of the water molecules from the betaCD cavity and enhancement of the complexation in solution. These results showed that oven-dried granulation of IBU and betaCD provided faster IBU dissolution than the physical mixture; air-dried granulation did not substantially affect the dissolution of IBU.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11485172     DOI: 10.1081/pdt-100002611

Source DB:  PubMed          Journal:  Pharm Dev Technol        ISSN: 1083-7450            Impact factor:   3.133


  9 in total

1.  Effect of selected non-ionic surfactants on the flow behavior of aqueous veegum suspensions.

Authors:  Ross A Kennedy; Michelle L Kennedy
Journal:  AAPS PharmSciTech       Date:  2007-03-30       Impact factor: 3.246

2.  Drug Release from ß-Cyclodextrin Complexes and Drug Transfer into Model Membranes Studied by Affinity Capillary Electrophoresis.

Authors:  Kinda A Darwish; Yahya Mrestani; Hans-Hermann Rüttinger; Reinhard H H Neubert
Journal:  Pharm Res       Date:  2016-01-19       Impact factor: 4.200

Review 3.  Cyclodextrins in drug delivery: an updated review.

Authors:  Rajeswari Challa; Alka Ahuja; Javed Ali; R K Khar
Journal:  AAPS PharmSciTech       Date:  2005-10-14       Impact factor: 3.246

4.  Characterization of cyclodextrin inclusion complexes of the anti-HIV non-nucleoside reverse transcriptase inhibitor UC781.

Authors:  Haitao Yang; Michael A Parniak; Charles E Isaacs; Sharon L Hillier; Lisa C Rohan
Journal:  AAPS J       Date:  2008-12-17       Impact factor: 4.009

5.  In Vitro and In Vivo Study of Poly(ethylene glycol) Conjugated Ibuprofen to Extend the Duration of Action.

Authors:  Anjali Nayak; Anurekha Jain
Journal:  Sci Pharm       Date:  2011-03-20

6.  Cyclodextrins in delivery systems: Applications.

Authors:  Gaurav Tiwari; Ruchi Tiwari; Awani K Rai
Journal:  J Pharm Bioallied Sci       Date:  2010-04

7.  Enhancement of transdermal delivery of ibuprofen using microemulsion vehicle.

Authors:  Liandong Hu; Qiaofeng Hu; Jianxue Yang
Journal:  Iran J Basic Med Sci       Date:  2014-10       Impact factor: 2.699

8.  Improved dissolution and anti-inflammatory activity of ibuprofen-polyethylene glycol 8000 solid dispersion systems.

Authors:  Kenneth C Ofokansi; Franklin C Kenechukwu; Richard O Ezugwu; Anthony A Attama
Journal:  Int J Pharm Investig       Date:  2016 Jul-Sep

Review 9.  Achievements in Thermosensitive Gelling Systems for Rectal Administration.

Authors:  Maria Bialik; Marzena Kuras; Marcin Sobczak; Ewa Oledzka
Journal:  Int J Mol Sci       Date:  2021-05-23       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.